Showing results (1361-1370 of 1,570) with videos related to

Sort By:
Pageof 157
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II studyE E Vokes, W R Panje, R L Schilsky, et al.
Leukemia|April 1, 1997
Pleiotropic expression of heterologous cytokine/receptor genes in HTLV-1 associated diseases: candidate TRS for chimeric gene therapyS J Greenberg, U Choi, P M Overturf, et al.
The Journal of Clinical Investigation|April 16, 2013
Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradationSaleemulla Mahammad, S N Prasanna Murthy, Alessandro Didonna, et al.
Cancer|December 6, 2002
Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinomaSupurna Ghosh, Hidayatullah G Munshi, Ratna Sen, et al.
Annals of Emergency Medicine|February 7, 2012
The Canadian Triage and Acuity Scale for children: a prospective multicenter evaluationJocelyn Gravel, Serge Gouin, Ran D Goldman, et al.
Journal of Oral Microbiology|December 9, 2021
The oral microbiome in alcohol use disorder: a longitudinal analysis during inpatient treatmentJ J Barb, K A Maki, N Kazmi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Hydroxychloroquine for the treatment of chronic graft-versus-host diseaseA L Gilman, K W Chan, A Mogul, et al.
Methods in Enzymology|January 23, 2016
Methods for Determining the Cellular Functions of Vimentin Intermediate FilamentsKaren M Ridge, Dale Shumaker, Amélie Robert, et al.
Frontiers in Cell and Developmental Biology|October 6, 2022
Expression of vimentin alters cell mechanics, cell-cell adhesion, and gene expression profiles suggesting the induction of a hybrid EMT in human mammary epithelial cellsSuganya Sivagurunathan, Amir Vahabikashi, Haiqian Yang, et al.
International Journal of MS Care|June 9, 2015
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled TrialRobert Yapundich, Angela Applebee, Francois Bethoux, et al.
Pageof 157